5F1L
Crystal structure of the bromodomain of BRD9 in complex with compound 9.
Summary for 5F1L
Entry DOI | 10.2210/pdb5f1l/pdb |
Related | 5EU1 5F1H |
Descriptor | Bromodomain-containing protein 9, 5-[3,5-dimethoxy-4-[(3-oxidanylazetidin-1-yl)methyl]phenyl]-1,3-dimethyl-pyridin-2-one (3 entities in total) |
Functional Keywords | bromodomain, inhibitor, transcription |
Biological source | Homo sapiens (Human) |
Total number of polymer chains | 2 |
Total formula weight | 29188.34 |
Authors | Bader, G.,Martin, L.J.,Steurer, S.,Weiss-Puxbaum, A.,Zoephel, A. (deposition date: 2015-11-30, release date: 2016-03-09, Last modification date: 2024-01-10) |
Primary citation | Martin, L.J.,Koegl, M.,Bader, G.,Cockcroft, X.L.,Fedorov, O.,Fiegen, D.,Gerstberger, T.,Hofmann, M.H.,Hohmann, A.F.,Kessler, D.,Knapp, S.,Knesl, P.,Kornigg, S.,Muller, S.,Nar, H.,Rogers, C.,Rumpel, K.,Schaaf, O.,Steurer, S.,Tallant, C.,Vakoc, C.R.,Zeeb, M.,Zoephel, A.,Pearson, M.,Boehmelt, G.,McConnell, D. Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor. J.Med.Chem., 59:4462-4475, 2016 Cited by PubMed: 26914985DOI: 10.1021/acs.jmedchem.5b01865 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.3 Å) |
Structure validation
Download full validation report